(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REXIMMUNE-C

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

REXIMMUNE-C

ST13

US500000078706667

Class

5

Filing

78706667

Registration

3269885

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

07/24/2026

Trademark type

Word

Nice classes

5

Filing date

09/03/2005

Registration date

07/24/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/13/2017

Last transaction

07/24/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/22/2005

First use in commerce

11/22/2005

Drawing code

4

Owner type

03

Owner location

SAN MARINO, CA, US

Examiner

SMITH, BRIDGETT G

Law office

M60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

GENVIVO, INC.
E. C. (pessoa física)
E. C. (pessoa física)

Representatives

Jean L. Batman Legal Venture Counsel, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationslesion-targeted vectory carrying immune response genes for use in the treatment of cancerinflammatory and immunologic disorders

Publications

History of USPTO decisions and trademark events.

35 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/24/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/30/2019

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/13/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/13/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/13/2017

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

02/08/2017

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

12/05/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/05/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

09/23/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/24/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/19/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/19/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/19/2013

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

12/10/2013

E815

TEAS SECTION 8 & 15 RECEIVED

12/10/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/20/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/20/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/20/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

07/24/2007

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

06/21/2007

ALIE

ASSIGNED TO LIE

06/21/2007

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/23/2007

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/22/2007

IUAF

USE AMENDMENT FILED

02/16/2007

EISU

TEAS STATEMENT OF USE RECEIVED

02/16/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

10/17/2006

PUBO

PUBLISHED FOR OPPOSITION

07/25/2006

NPUB

NOTICE OF PUBLICATION

07/05/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/07/2006

ALIE

ASSIGNED TO LIE

05/22/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/12/2006

ALIE

ASSIGNED TO LIE

03/24/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/17/2006

DOCK

ASSIGNED TO EXAMINER

03/17/2006

NWAP

NEW APPLICATION ENTERED

09/12/2005

Continuous trademark protection

Get notified about every new filing that threatens REXIMMUNE-C or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.